Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial

BACKGROUND: This randomized, double-blind trial evaluated sugammadex-mediated recovery time from rocuronium- or vecuronium-induced moderate (M-) or deep (D-) neuromuscular block in morbidly obese adults dosed by actual (ABW) or ideal body weight (IBW). METHODS: Adults with BMI ≥40 kg/m(2) were rando...

Descripción completa

Detalles Bibliográficos
Autores principales: Horrow, Jay C., Li, Wen, Blobner, Manfred, Lombard, John, Speek, Marcel, DeAngelis, Matthew, Herring, W. Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913453/
https://www.ncbi.nlm.nih.gov/pubmed/33639839
http://dx.doi.org/10.1186/s12871-021-01278-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913453/
https://www.ncbi.nlm.nih.gov/pubmed/33639839
http://dx.doi.org/10.1186/s12871-021-01278-w

Ejemplares similares